AbbVie Aktie
| 227,95USD | 0,48USD | 0,21% |
WKN DE: A1J84E / ISIN: US00287Y1091
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 50 000 | 50 000 | 50 000 | 55 000 | 57 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,12 | 1,16 | 1,09 | 1,02 | 1,07 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 27 928 | 28 463 | 33 002 | 25 582 | 29 062 |
| Summe Anlagevermögen | 118 601 | 110 342 | 101 709 | 109 579 | 104 898 |
| Summe Aktiva | 146 529 | 138 805 | 134 711 | 135 161 | 133 960 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 131 093 | 121 518 | 124 314 | 131 797 | 137 188 |
| Summe Eigenkapital | 15 436 | 17 287 | 10 397 | 3 364 | -3 228 |
| Summe Passiva | 146 529 | 138 805 | 134 711 | 135 161 | 133 960 |
Adresse
| 1 North Waukegan Road, 60064-6400 North Chicago | |
| Telefon | +1 (847) 932-7900 |
| Internet | http://www.abbvie.com |
Management
|
Azita Saleki-Gerhardt
Chief Operations Officer & Executive VP |
|
Brett J. Hart
Independent Director |
|
Brian L. Durkin
Vice President |
|
David R. Purdue
Senior Vice President & Controller |
|
Edward J. Rapp
Independent Director |
|
Esteban Plata
Vice President-Western Europe & Canada |
|
Frederick H. Waddell
Independent Director |
|
Jeffrey Ryan Stewart
Chief Commercial Officer & Executive VP |
|
Jennifer L. Davis
Independent Director |
|
Latif Akintade
SVP-Medical Affairs & Health Economics |
|
Liz Shea
Senior Vice President-Investor Relations |
|
Melody B. Meyer
Independent Non-Executive Director |
|
Nicholas Donoghoe
Executive VP, Chief Business & Strategy Officer |
|
Nicole Mowad-Nassar
Senior Vice President & President-Specialty |
|
Perry C. Siatis
Secretary, Executive VP & General Counsel |
|
Rebecca Brown Roberts
Independent Director |
|
Robert A. Michael
Chairman & Chief Executive Officer |
|
Robert J. Alpern
Independent Director |
|
Roopal Thakkar
Chief Scientific Officer, Executive VP-R&D |
|
Roxanne Schuh Austin
Lead Independent Director |
|
Sanjay Narayan
Chief Ethics & Compliance Officer, Senior VP |
|
Scott T. Reents
Chief Financial Officer & Executive Vice President |
|
Susan E. Quaggin
Independent Director |
|
Thomas C. Freyman
Independent Director |
|
Thomas J. Falk
Independent Director |
|
Timothy J. Richmond
Chief Human Resources Officer & Executive VP |
|
William H. L. Burnside
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.